The "Glucose Goddess" built a brand around her blood sugar balancing hacks. She said a few simple swaps to her diet boosted ...

The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The parent of a child who wore the device to manage diabetes described failed alerts and inaccurate readings in a complaint.

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

If you’re trying to figure out whether now’s the time to buy, hold, or even sell DexCom stock, you’re not alone. After all, its share price has been a bit of a roller coaster lately. Over the last ...

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by critical comments from President Donald Trump. The president's tone and the ...

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital ...

From cardiac ablation devices to OTC glucose sensors, explore how breakthrough medical technologies are disrupting ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...